Rodrigo Manso-Gil

Madrid, MD 28029, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia.

Journal: Leukemia

Published: January 23, 2026

Incidence proportion and divergent performance of risk factors for carbapenem-resistant Gram-negative bacteria bloodstream infections across haematological cohorts.

Incidence proportion and divergent performance of risk factors for carbapenem-resistant Gram-negative bacteria bloodstream infections across haematological cohorts.

Journal: JAC-antimicrobial resistance

Published: January 21, 2026

Nabiximols oromucosal spray in patients with chronic graft-versus-host disease: effects on sclerodermatous features and refractory muscle cramps.

Nabiximols oromucosal spray in patients with chronic graft-versus-host disease: effects on sclerodermatous features and refractory muscle cramps.

Journal: Bone marrow transplantation

Published: January 30, 2025

Real-World Impact of Deep Targeted Sequencing on Erythrocytosis and Thrombocytosis Diagnosis: A Reference Centre Experience.

Real-World Impact of Deep Targeted Sequencing on Erythrocytosis and Thrombocytosis Diagnosis: A Reference Centre Experience.

Journal: Cancers

Published: August 18, 2024

Isolated Ischemic Inferior Rectus Paresis Related to Patent Foramen Ovale.

Isolated Ischemic Inferior Rectus Paresis Related to Patent Foramen Ovale.

Journal: Neuro-ophthalmology (Aeolus Press)

Published: June 27, 2024

COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant.

COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant.

Journal: Cancers

Published: November 13, 2023

COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study.

COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study.

Journal: Cancers

Published: November 30, 2022

CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.

CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.

Journal: Blood advances

Published: May 26, 2022

Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.

Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.

Journal: Journal of hematology & oncology

Published: August 05, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026